Inhibitor Therapeutics, Inc. 10-K Cybersecurity GRC - 2025-03-28

Page last updated on March 28, 2025

Inhibitor Therapeutics, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2025-03-28 16:10:22 EDT.

Filings

10-K filed on 2025-03-28

Inhibitor Therapeutics, Inc. filed a 10-K at 2025-03-28 16:10:22 EDT
Accession Number: 0001641172-25-001190

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Item 1C. Cybersecurity Cybersecurity We recognize the importance of assessing, identifying, and managing material risks associated with cybersecurity threats, as such term is defined in Item 106(a) of Regulation S-K. These risks include, among other things: operational risks, intellectual property theft, fraud, extortion, harm to employees or customers and violation of data privacy or security laws. Our Chief Financial Officer manages our risk management program to assess third party risk exposure to identify and mitigate risks from vendors, suppliers, and other business partners. We have not had any cybersecurity issues in the past. We maintain cybersecurity insurance coverage (first and third-party) with an insurance carrier that is a leader in the cybersecurity insurance industry. Identifying and assessing cybersecurity risk is integrated into our overall risk management systems and processes. We are cognizant of cybersecurity risks related to our business, technical operations, privacy and compliance issues, IT security, governance, risk and compliance reviews. To defend, detect and respond to cybersecurity incidents, we are proactive in privacy and cybersecurity issues with vendors and conduct employee training as needed, monitor emerging laws and regulations related to data protection and information security and implement appropriate changes. Cybersecurity risks are evaluated when determining the selection and oversight of applicable third-party service providers and potential fourth-party risks when handling and/or processing our employee, business or vendor data. In addition to new vendor onboarding, we would perform risk management during potential third-party cybersecurity compromise incidents, should they occur, to identify and mitigate risks to us from third-party incidents.

Company Information